<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=2179646889074564&amp;ev=PageView&amp;noscript=1">

Innovating at the speed of AI

The world has undergone a rapid and transformative shift since the adoption of AI. This is particularly evident in biopharma, where the possibility of a truly ground-breaking solution that accelerates research, disease diagnosis and trial-matching is at hand.

We’ve assembled an exceptional team to do just that, comprised of individuals with an indisputable track record of excellence.

Our quest is backed by savvy investors who support our vision of GenAI applications for the Pharma sector.

Meet the team

Ryght | Simon Arkell

Simon Arkell

Co-Founder and CEO
Read more Close
Simon is a hi tech entrepreneur and investor with a focus on AI and healthcare technology. Co-founder of 7 venture backed companies, including Deep Lens, Predixion Software and Versifi, which together raised over $100M in venture backing. All three were acquired.
Ryght | Alex Dickinson

Alex Dickinson

Co-Founder and Chairman
Read more Close
Co-founder/Chair/CEO: ChromaCode (COVID XPrize winner); Helixis (acquired by Illumina) and Luxtera (acquired by Cisco). Board member Gencove (low pass sequencing) and previously PRA Health Sciences (public, acquired by ICON). Seven year Illumina SVP (led BaseSpace and PopSeq businesses). Began career in research at Bell Labs; co-inventor of the CMOS fingerprint sensor.
Ryght | Chadi Nabhan

Chadi Nabhan

Chief Medical Officer & Head of Strategy
Read more Close

Dr. Chadi Nabhan is the Chief Medical Officer and Head of Strategy at Ryght, bringing over 20 years of oncology and leadership experience to drive innovation and strategic vision.

His past roles include SVP and Chairman of the POA at Caris Life Sciences, VP and CMO at Cardinal Health Specialty Solutions, and EVP and CMO at Aptitude Health. Academically, he has served as an Associate Professor of Medicine and the Director of Outpatient Cancer Clinics at the University of Chicago, and before that, Chief of Oncology and Cancer Institute Medical Director at Advocate Lutheran General Hospital in Park Ridge, IL. Dr. Nabhan is an esteemed author, podcaster, and speaker, recognized for his contributions to medical oncology and clinical research. 

Ryght | Sara Dada

Sara Dada

Senior Director of Product
Read more Close
Sara Dada is an experienced Product Management professional based in the San Francisco Bay Area. She has previously served on the product team of a B2B SaaS company, consulted for various startups, and worked as a data analyst for a venture fund. She studied Business Administration and Technology Ethics at Cal Poly SLO.
Ryght | Dylan Wallace

Dylan Wallace

Director of Business Development
Read more Close
As Director of Business Development, Dylan leads Ryght’s efforts to build relationships with customers and generate new business. Coming from the CRO space, at IQVIA Biotech, he understands the needs of biotech clients as well as the nuances of the clinical trial landscape. Dylan studied Business Administration and International Affairs at the University of North Carolina Wilmington and still calls Wilmington his home. When he is not working, you can find him at the pickleball courts, on the golf course, traveling the world, or spending time with his family.
Ryght | Tarek Sherif

Tarek Sherif

Advisor
Read more Close

Tarek Sherif, former CEO and co-founder, Medidata Solutions & Ryght Advisor, co-founded Medidata Solutions in 1999, where he played a pivotal role in transforming clinical research by automating and digitizing trials through cloud-based solutions. Under his leadership, Medidata became the industry standard for clinical trial data management and analytics, by delivering leading edge technology along with customer centric services.  

Sherif brings a wealth of experience and a proven track record in pioneering cloud-based solutions and automating clinical trials.

Investors

Ryght's initial funding is supported by leading investors with a shared vision to improve healthcare by leveraging advances in AI technology. The initial round was led by Virtue with participation from AIX Ventures, Iaso Ventures, Page One Ventures, Top Harvest Capital, and additional strategic angel investors.
sb_investors-virtue sb_investors-AIX Iaso Ventures sb_investors-page-one sb_investors-top-harvest Foothill Ventures Logo LDV Partners

Partners

We understand that the foundation of transformative life sciences solutions rests on cutting-edge technology, robust security, and infinite scalability. To ensure our customers experience unparalleled success, we strategically partner with the industry’s leading technology and cloud service providers. Our meticulously selected network of partners empowers us to deliver secure, scalable, and cutting-edge AI-driven solutions tailored for the unique challenges of the life sciences sector. 
databricks logo AWS Logo Microsoft Azure Logo Lucem Health Logo Nvidia Logo Hugging Face Logo

Ready to learn more?

Schedule a Demo

Get in touch